Armata Pharmaceuticals (ARMP) FCF Margin (2013 - 2020)

Armata Pharmaceuticals (ARMP) reported FCF Margin of 13319.35% for Q2 2020, down 11.6% sequentially from 11935.0% in Q4 2017.

Armata Pharmaceuticals (ARMP) FCF Margin (2013 - 2020) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 6 years of FCF Margin data on file, last reported at 13319.35% in Q2 2020.

For the quarter ending Q2 2020, FCF Margin changed N/A year-over-year to 13319.35%; the trailing twelve-month figure through Jun 2020 stood at 13433.33% (changed N/A YoY), and the FY2017 full-year result was 8043.48%, down 385694.0% from the prior year.
FCF Margin slipped to 13319.35% in Q2 2020, from 11935.0% in the prior quarter.
In the past five years, FCF Margin ranged from a high of 1647.37% in Q3 2017 to a low of 13319.35% in Q2 2020.
A 3-year average of 8053.3% and a median of 10475.0% in 2017 frame the typical range for FCF Margin.
Across the five-year window, FCF Margin sank 906928 bps in 2016 and surged 924918 bps in 2017, its largest moves.
Tracing ARMP's FCF Margin over 3 years: stood at 6868.18% in 2016, then tumbled by 74 bps to 11935.0% in 2017, then declined by 12 bps to 13319.35% in 2020.
Business Quant data shows ARMP's FCF Margin at 13319.35% in Q2 2020, 11935.0% in Q4 2017, and 1647.37% in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	10.45%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	43.35%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	23.53%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Armata Pharmaceuticals	191.29 Mn	186.49 Mn	-	-

Download Data